文献速递脑血管病

M2小胶质细胞细胞外囊泡miR-124通过AAK1/NOTCH调控缺血性卒中神经干细胞分化

M2 Microglia Extracellular Vesicle miR-124 Regulates Neural Stem Cell Differentiation in Ischemic Stroke via AAK1/NOTCH.
PubMed 文献 · Stroke · 2023-08-10

研究探讨M2小胶质细胞来源小细胞外囊泡(M2-sEVs)中miR-124促进缺血脑内神经干细胞增殖与神经元分化的机制;小鼠短暂大脑中动脉闭塞后连续7天静脉注射M2-sEVs,可降低脑萎缩体积、神经功能评分和死亡率,该效应在敲低miR-124后消失;蛋白组学提示AAK1与Notch结合促进神经干细胞向神经元而非星形胶质细胞分化。

要点

  • M2-sEVs静脉注射促进短暂大脑中动脉闭塞小鼠的神经功能恢复。
  • M2-sEVs降低脑萎缩体积、神经功能评分和死亡率,敲低miR-124后效应消失。
  • AAK1/Notch通路介导miR-124促神经干细胞向神经元分化。

核心结论

  • M2-sEVs携带的miR-124通过AAK1/Notch通路促进神经干细胞增殖与分化,从而促进缺血性卒中后功能恢复。
  • 靶向M2-sEVs可能成为脑恢复的潜在治疗策略。

研究设计与样本

  • 小鼠短暂大脑中动脉闭塞后,连续7天静脉注射携带或敲低miR-124的M2-sEVs。
  • 在不同时间点检测脑萎缩体积、神经功能评分和神经发生程度。
  • 对经不同sEVs处理的神经干细胞进行蛋白组学分析,定量靶蛋白浓度并进行生物信息学分析。

主要发现

  • M2-sEVs移植促进短暂大脑中动脉闭塞损伤后的神经功能恢复。
  • M2-sEVs治疗降低脑萎缩体积、神经功能评分和死亡率;敲低M2-sEVs中的miR-124后该效应消失。
  • M2-sEVs在体内促进成熟神经元神经干细胞的增殖和分化。
  • 蛋白组学分析显示AAK1是神经干细胞中的关键响应蛋白;AAK1与Notch结合促进神经干细胞分化为神经元而非星形胶质细胞。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Small extracellular vesicles (sEVs) derived from M2 microglia (M2-microglia-derived small extracellular vesicles [M2-sEVs]) contribute to central nervous system repair, although the underlying mechanism remains unknown. In this study, we aimed to identify the mechanism through which microRNA-124 (miR-124) carried in sEVs promotes neural stem cell (NSC) proliferation and neuronal differentiation in the ischemic mouse brain. METHODS: M2-sEVs with or without miR-124 knockdown were injected intravenously for 7 consecutive days after transient middle cerebral artery occlusion surgery. The atrophy volume, neurological score, and degree of neurogenesis were examined at different time points after ischemic attack. NSCs treated with different sEVs were subjected to proteomic analysis. Target protein concentrations were quantified, and subsequent bioinformatic analysis was conducted to explore the key signaling pathways. RESULTS: M2-sEV transplantation promoted functional neurological recovery following transient middle cerebral artery occlusion injury. M2-sEV treatment decreased the brain atrophy volume, neurological score, and mortality rate. The effect was reserved by knockdown of miR-124 in M2-sEVs. M2-sEVs promoted proliferation and differentiation of mature neuronal NSCs in vivo. Proteomic analysis of NSC samples treated with M2-sEVs with and without miR-124 knockdown revealed that AAK1 (adaptor-associated protein kinase 1) was the key responding protein in NSCs. The binding of AAK1 to Notch promoted the differentiation of NSCs into neurons rather than astrocytes. CONCLUSIONS: Our data suggest that AAK1/Notch is the key pathway in NSCs that responds to the miR-124 carried within M2-sEVs in the ischemic brain. M2-sEVs carrying ample quantities of miR-124 promote functional recovery after ischemic stroke by enhancing NSC proliferation and differentiation. Targeting of M2-sEVs could represent a potential therapeutic strategy for brain recovery.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Song Y, Shi R, Liu Y, et al. M2 Microglia Extracellular Vesicle miR-124 Regulates Neural Stem Cell Differentiation in Ischemic Stroke via AAK1/NOTCH. Stroke. 2023. PMID: 37586072. doi:10.1161/STROKEAHA.122.041611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。